Patent Assignment
Reel/Frame 063903/0246
Assignment of Assignor's Interest
Recorded: 2023-06-09
Pages: 10
Assignor
DMK PHARMACEUTICALS CORPORATION
Executed: 2023-05-25
Assignee
DMK PHARMACEUTICALS CORPORATION
50 DIVISION STREET SUITE 501, SOMERVILLE, NEW JERSEY, 08876
Covered Properties
(14)
Enantiomerically Pure Opioid Diarylmethylpiperzine and Methods of Using Same
Method of Treating Depression with Delta Receptor Agonist Compounds
Method of Treating Sexual Dysfunctions with Delta Opioid Receptor Agonist Compounds
Cardioprotective Delta Opioid Receptor Agonists and Methods of Using Same
Enantiomerically Pure Opioid Diarylmethylpiperazine as a Cardioprotection Agent
Compositions of Novel Opioid Compounds and Method of Use Thereof
Method of Treating Parkinson's Disease with Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity
Delta Opioid Receptor Agonist Compounds
Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity
Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity
Delta Opioid Agonist Mu Opioid Antagonist Compositions and Methods for Treating Parkinsons Disease
An Opioid for Use to Reduce and/or Treat Drug Addiction
Delta Opioid Agonist, Mu Opioid Antagonist Compositions and Methods for Treating Parkinsons Disease
Application:
17/198,479 →
Publication:
US 2021/0220349
Opioid for Use to Reduce and/or Treat Drug Addiction
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 25, 2004
From: CHANG, KWEN-JEN; PENDERGAST, WILLIAM; GENGO, PETER J.; MA, XIN
To: ARDENT PHARMACEUTICALS, INC.
Reel/Frame 015012/0100 →
Assignment of Assignor's Interest
Sep 9, 2005
From: CHANG, KWEN-JEN
To: ARDENT PHARMACEUTICLAS, INC.
Reel/Frame 016767/0229 →
Assignment of Assignor's Interest
Sep 7, 2006
From: ARDENT PHARMACEUTICAL, INC.
To: MOUNT COOK BIOSCIENCES, INC.
Reel/Frame 018207/0396 →
Assignment of Assignor's Interest
Nov 9, 2009
From: MT. COOK PHARMA, INC.
To: ENTHALPY ANALYTICAL, INC.
Reel/Frame 023486/0174 →
Equitable Lien
Feb 17, 2010
From: MT. COOK PHARMA, INC. (PREVIOUSLY DOING BUSINESS AS MOUNT COOK BIOSCIENCES, INC.)
To: VERSI, EBRAHIM
Reel/Frame 023957/0442 →
Lien
Mar 23, 2010
From: MT. COOK PHARMA, INC.
To: ENTHALPY ANALYTICAL, INC.
Reel/Frame 024127/0118 →
Lien
Apr 23, 2010
From: ENTHALPY ANALYTICAL, INC.
To: ENTA HOLDING LLC
Reel/Frame 024282/0605 →
Assignment of Assignor's Interest
Apr 23, 2010
From: ENTHALPY ANALYTICAL, INC.
To: ENTA HOLDING LLC
Reel/Frame 024278/0419 →
Sale of Assets
Jun 28, 2011
From: MT COOK PHARMA, INC.
To: VERSI, EBRAHIM
Reel/Frame 026511/0230 →
Change of Name
Mar 26, 2012
From: MOUNT COOK BIOSCIENCES, INC.
To: MT. COOK PHARMA, INC.
Reel/Frame 027930/0493 →
Assignment of Assignor's Interest
May 10, 2012
From: VERSI, EBRAHIM
To: VERSI GROUP, LLC
Reel/Frame 028186/0765 →
Assignment of Liens
May 21, 2013
From: ENTHALPY ANALYTICAL, INC. AND ENTA HOLDING LLC
To: VERSI GROUP, LLC
Reel/Frame 030453/0956 →
Assignment of Assignor's Interest
Mar 29, 2023
From: EBRAHIM VERSI; BRUCE E. REIDENBERG
To: VERSI GROUP, LLC
Reel/Frame 063150/0352 →
Assignment of Assignor's Interest
Mar 29, 2023
From: EBRAHIM VERSI
To: VERSI GROUP, LLC
Reel/Frame 063150/0585 →
Assignment of Assignor's Interest
May 26, 2023
From: VERSI GROUP LLC
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 063773/0672 →